Technology · Health & biomedicine / Regenerative & personalized medicine

Organoid & organ-on-chip drug screening

Stem-cell-derived 3D organ models used as in-vitro platforms to screen drugs, as a supplement or alternative to animal tests — early and largely pilot, with no system fully qualified for broad regulatory use as of late 2024.

Maturity 4/9 Risk: high Advanced therapies Research tools & R&D services US · EU verified 2026-10-16 · 6 Sources

1 · What it gives

Organoids are 3D structures derived from stem cells that mimic key architecture and function of human organs and serve as in-vitro platforms for drug screening. The technology is meant as an alternative or supplement to animal models in preclinical development. It is early and largely at pilot stage: as of late 2024 no systems were fully qualified for broad regulatory use.

2 · What it replaces 6

D2	Crop disease forecasting models, spore traps, pheromone and smart pest traps and field diagnostics — spray when risk is real instead of calendar-based fungicide and insecticide programmes Replaces: Fixed-interval ("calendar") protective fungicide sprays and routine insecticide applications regardless of pest pressure	EAC
D1	Fermentation (stainless and single-use bioreactors, solid-state reactors) and downstream equipment (centrifuges, filtration, spray and fluid-bed drying, formulation) for local production of enzymes, microbial products and fermentation ingredients instead of chemical-synthesis plants and imports Replaces: Chemical-synthesis routes and imports for the products in FI-, FD-, I- and A-series articles (enzymes, organic acids, vitamins, microbial …	EAC
D2	On-farm culture, PCR panels, rapid tests and veterinary laboratory services for livestock and aquaculture — treat what is diagnosed instead of blanket and prophylactic antibiotic treatment Replaces: Blanket treatment of every clinical mastitis case, group metaphylaxis on suspicion, prophylactic antibiotics in hatcheries and ponds, …	DIAG
D3	Augmentative biological control in greenhouse vegetables instead of insecticide and acaricide programmes Replaces: Calendar sprays of insecticides and acaricides (organophosphates, neonicotinoids, pyrethroids, abamectin) against whitefly, thrips, aphids, …	MACRO
D1	Baking enzymes (fungal amylase, maltogenic amylase, xylanase, glucose oxidase, lipase) plus ascorbic acid instead of potassium bromate and azodicarbonamide as flour treatment agents Replaces: Potassium bromate (KBrO₃) and azodicarbonamide (ADA) used as oxidizing flour improvers/dough conditioners; part of chemical emulsifier use …	FOOD
D1	Biochar as a composting and manure additive, a feed additive and a low-cost sorbent for water and soil treatment — instead of coal-based activated carbon, chemical odour and ammonia binders, and part of clay toxin binders Replaces: Coal- or fossil-based activated carbon for low-demanding sorption duties; chemical odour/ammonia control in litter and compost; part of the …	AGROCHEM

3 · How to implement 3 steps

1
Design the model
Design the device or model.
2
Source human cells
Source human cells for tissue reconstruction.
3
Build the microenvironment
Establish the microenvironment with microfluidics and screen the compounds.

4 · Who delivers

Matched suppliers (matched automatically)

Sartorius	Germany	Producer	active
Green Lagoon Technology Sdn Bhd	Malaysia	Producer	active
Lootah BioFuels	United Arab Emirates	Producer	active
Paul Mueller Company	United States	Equipment	active
Pyrogreen Energy	China	Producer	active
AgriFam PT	Indonesia	Producer	active
Biowatt-Biogas	China	Services / consulting	active
Liselo Labs	South Africa	Research / RTO	active
FENRI Co., Ltd.	Taiwan	Not classified	active
Fermelanta	Japan	Producer	active
AGROSAVIA	Colombia	Research / RTO	active
ATTO	Brazil	Distributor	active

Leading companies and institutes (from the brief)

Mimetas, Alveolix, CN Bio and Draper are named as organ-on-a-chip providers; GSK and AstraZeneca as industry users. Others are matched by the portal under Advanced therapies and Research tools.

5 · Rules & route to market

Route into Russia / EAEU: EAC · EAEU accredited bodies / Rosakkreditatsiya
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)

United States

The US FDA is establishing frameworks and guidance for validating and qualifying these new methods.

European Union

The European Medicines Agency is likewise establishing frameworks and guidance for validation and qualification.

China

The sources reviewed on 2026-10-16 identified no China regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.

6 · Money: tenders & grants

Grant	Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the … National Institutes of Health · United States	Aug 18, 2027 306 days
Grant	First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based … National Institutes of Health · United States	Oct 15, 2027 364 days
Grant	ARMY APPLICATIONS LAB BROAD AGENCY ANNOUNCEMENT FOR DISRUPTIVE APPLICATIONS Dept of the Army -- Materiel Command · United States	Apr 4, 2029 901 days
Grant	Automated Scientific Discovery – Food (RAISE pilot) European Commission · EU	Feb 2, 2027 109 days
Grant	Boosting Innovative GEOINT - Science & Technology Broad Agency Announcement (BIG-ST BAA) National Geospatial-Intelligence Agency · United States	Dec 14, 2026 59 days

7 · Tech stack & innovations

Main risks from the sources: biological complexity causing inconsistent results, lack of standardised protocols, and high labour and infrastructure cost that limits industrial scale.

Sources 6

Nature.com — www.nature.com 2026-10-16
Pmc.ncbi.nlm.nih.gov — pmc.ncbi.nlm.nih.gov 2026-10-16
Cnpharm.com — www.cnpharm.com 2026-10-16
Pmc.ncbi.nlm.nih.gov — pmc.ncbi.nlm.nih.gov 2026-10-16
Pmc.ncbi.nlm.nih.gov — pmc.ncbi.nlm.nih.gov 2026-10-16
Gao.gov — www.gao.gov 2026-10-16